Running on Empty: Navigating the GLP-1 and GIP/GLP-1 Receptor Agonist Drug Shortage Kimmy Nguyen May 27, 2024 4 min read Updated: Oct 30, 2025 By Sydnie Twillmann, PharmD Glucagon-like peptide 1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have been making the headlines recently, for more reasons than one
This means your digestive system partially normalizes over time, and foods that were completely off-limits in week one may be manageable (in moderation) by month three or four
Refer to Table 10 and Figure 1
Every plan is tailored to your unique metabolism, hormones, and health goals, ensuring results that are both effective and sustainable
Grfico 1
While this modest weight loss can provide health benefits, it is substantially less than what is achieved with prescription semaglutide